2018
DOI: 10.1002/adtp.201800117
|View full text |Cite
|
Sign up to set email alerts
|

The Inhibition of Lipid A Biosynthesis—The Antidote Against Superbugs?

Abstract: After many years of success in the battle against infectious diseases, ground is being lost in this fight with the worldwide increasing appearance of "superbugs," which are resistant to most antibiotics in clinical use. The impact of superbugs on the older population, healthcare-associated patients or patients with a compromised immune system is highly worrisome since no treatment options are available in some cases, especially for Gram-negative pathogens. Efforts are currently devoted to develop novel chemica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 91 publications
(226 reference statements)
0
1
0
Order By: Relevance
“…The central role of lipid A in the pathogenesis of sepsis makes it a good target for antibiotic strategies [26]. The central role of lipid A in the pathogenesis of sepsis makes it a good ta antibiotic strategies [26].…”
Section: Endotoxin: Structure and Characteristicsmentioning
confidence: 99%
“…The central role of lipid A in the pathogenesis of sepsis makes it a good target for antibiotic strategies [26]. The central role of lipid A in the pathogenesis of sepsis makes it a good ta antibiotic strategies [26].…”
Section: Endotoxin: Structure and Characteristicsmentioning
confidence: 99%
“…15 In the present study, the key enzymes in lipid A biosynthesis pathway which are essential for the cell wall synthesis and pathogenesis of bacteria cell were explored as drug target. 16 Lipid A biosynthesis pathway starts with acylation of UDP-N-acetylglucosamine (UDP-GlcNAc) with 3-hydroxymyristoate-acylcarrier-protein (3-OH-c14-ACP) to form UDP-3-O-acyl-N-acetylglucosamine (UDP-3-O-acylGlcNAc). This reaction is catalyzed by UDP-GlcNAc acyltransferase (LpxA) (Fig.…”
Section: Introductionmentioning
confidence: 99%